The Series on “Cardio-Oncology” is edited by Pei-Wei Shueng from National Yang Ming Chiao Tung University, Yen-Wen Wu from Far Eastern Memorial Hospital and Long-Sheng Lu from Taipei Medical University.

Pei-Wei Shueng, MD
Assistant Professor, National Yang Ming Chiao Tung University, Taipei, Taiwan
Chairman, Department of Radiology, Far Eastern Memorial Hospital, New Taipei City, Taiwan
Chief, Department of Radiation Oncology, Far Eastern Memorial, New Taipei City, Taiwan

Dr. Shueng has been instrumental in pioneering new technology in radiation oncology including IMRT (intensity-modulated radiation therapy), IGRT (image-guided radiation therapy), SBRT (stereotactic body radiation therapy) in Taiwan. Dr. Shueng has published over 110 original articles in peer-reviewed (SCI) journals. He completed the first Asian experience of total marrow irradiation (TMI) using helical tomotherapy in 2006. He and his colleague made design & innovation for first global experience of Helical Irradiation of Total Skin (HITS) for intractable T-cell skin lymphoma in 2012. His team got the Award for Symbol of National Quality (SNQ) for TomoTherapy (2016-2020) and heart-sparing radiotherapy of breast cancer (2020) in Taiwan.

Yen-Wen Wu, MD, PhD, FACC, FESC
Director of Cardiovascular Medical Center, Chief of Cardiology Division, Far Eastern Memorial Hospital, New Taipei City, Taiwan
Adjunct Professor, National Yang Ming Chiao Tung University, Faculty of Medicine, Taipei, Taiwan
Chair, Cross-Discipline Working Group in Taiwan Society of Cardiology

Yen-Wen Wu, MD, PhD holds the position of Director of Cardiovascular Medical Center, Chief of Cardiology Division at Far Eastern Memorial Hospital and Adjunct Professor of School of Medicine, National Yang Ming Chao Tung University.

She concurrently serves as Taiwan Association of Lipid Educators, Chair, Cross-Discipline Working Group in Taiwan Society of Cardiology, Chair, Nuclear Cardiology Committee in Society of Nuclear Medicine, R.O.C, Executive Board Member of the Society of Nuclear Medicine, R.O.C, Taiwan Hypertension Society, Taiwan Society of Lipids and Atherosclerosis and Taiwan Society of Atherosclerosis & Vascular Diseases.

Dr. Wu received her MD degree from College of Medicine, National Taiwan University; and her Master and PhD degrees from Graduate Institute of Clinical Medicine, National Taiwan University. She did her internal medicine/nuclear medicine residency and cardiology fellowship at National Taiwan University Hospital, and still serves as Adjunct Attending Physician at Departments of Internal Medicine and Nuclear Medicine, National Taiwan University Hospital. Dr. Wu has published over 205 original articles in peer-reviewed (SCI) journals, and is currently the Deputy Editor-in-Chief of Acta Cardiologica Sinica (ACS), and Annals of Nuclear Medicine and Molecular Imaging (ANMMI). Dr. Wu is a Fellow of European Society of Cardiology (FESC) and American College of Cardiology (FACC), and a member of Society of Nuclear Medicine and Molecular Imaging (SNMMI), American Society of Nuclear Cardiology (ASNC), and American Heart Association (AHA).

She has long-standing interest in cardiovascular imaging, nuclear medicine and molecular imaging, biomarkers, and heart failure, and has been recognized for her research work with the numerous awards and honors she received from domestic and international scientific bodies, including Cardiovascular Young Investigator Award of the Society of Nuclear Medicine (SNM) (2007/06/06) and Y.Z. Hsu Scientific Award - Outstanding Professor Award (2015/08/14).

Long-Sheng Lu M.D. PhD
Assistant Professor, Graduate Institute of Biomedical Materials and Tissue Engineering, International Ph.D. Program in Biomedical Engineering, International Ph.D. Program for Cell Therapy and Regeneration Medicine, Taipei Medical University, Taipei, Taiwan
Deputy Director, Clinical Research Center Attending Physician, Department of Radiation Oncology, Taipei Medical University Hospital, Taipei, Taiwan

Lu is interested in translational radiation oncology and personalized cancer medicine. With clinical specialty in breast and gastrointestinal cancers, his research is aiming at cardiopulmonary protection, radiation-assisted immunotherapy and personalized cancer medicine. Moreover, he initiated and sat in the molecular tumor board of TMU (2018-) and developed microfluidic circulating tumor cell technologies for personalized cancer medicine. He has published 38 SCI papers, 3 book chapters and holds 6 patents (licensed to Cancerfree and Bosomeer). He is PI of 5 active grants from Taiwanese government and private sponsors, and recipients of Taiwanese academic and innovative entrepreneurship awards including Junior Faculty Career Development Award from Taiwan Society for Therapeutic and Radiation Oncology (2018), National Innovation Award (2019, 2020) and FITI Entrepreneurship Award (2017, 2018) from Taiwanese Ministry of Science and Technology.

Main Purpose of the Series
The main purpose of this special series is to highlight efforts from Taiwan Society for Therapeutic Radiology and Oncology (TASTRO) to promote cardio-oncology awareness. TASTRO members integrate evidences from basic science, epidemiology, radiation physics, and clinical radiation oncology into an updated view about cardiovascular responses to therapeutic ionizing radiation exposure and firsthand clinical experiences in Taiwan. Moreover, a perspective from Taiwan Society of Cardiology will enrich our audience with viewpoints from cardiologists, who are now our indispensable teammates to maximize long-term survival of cancer patients. Hopefully this primer will stimulate multidisciplinary collaborations and bring about real world impacts to this rapidly evolving field.

Series outline:

1. Imaging Modalities on Detecting Cancer Treatment Related Cardiovascular Dysfunction
2. Cardiovascular evaluation before radiotgerapy for breast cancer patients
3. Ionizing radiation induced mitochondrial fission and phenotypic switch in vascular smooth muscle cells
4. Initial experience for implementation of a cardio-oncology program for breast cancer patients receiving modern radiotherapy in a tertiary institute
5. The risk of cardiovascular toxicity caused by cancer radiotherapy (review)
6. Cardiac toxicity during breast cancer patients who received left side breast radiotherapy and trastuzumab
7. Comparison proton and photon for Lt breast cancer received radiotherapy
8. Cardiac dosage comparison among various partial breast irradiation techniques
9. Cardiovascular implantable electronic devices may tolerate high dose radiotherapy: an updated case report with long term follow-up
10. Marked local and distant response of heavily treated breast cancer with cardiac metastases treated by combined low dose radiotherapy, low dose immunotherapy and hyperthermia: a case report
11. The related topic about the implementation or guideline of the cardio-oncology program in South Korea ( still undetermined)
12. Application of Abches system for SBRT of lung cancer (or breast cancer)/SBRT induced pericairdal effusion ( cardiac toxicities): case report
13. A review of cardiotoxicity in thoracic radiotherapy

Disclosure:
The series “Cardio-Oncology” was commissioned by the editorial office, Therapeutic Radiology and Oncology without any sponsorship or funding. Dr. Pei-Wei Shueng, Dr. Yen-Wen Wu and Dr. Long-Sheng Lu are serving as the unpaid Guest Editors for the series.